The prodigiosins: A new family of anticancer drugs

Current Cancer Drug Targets

Volumn 3, Issue 1, 2003, Pages 57-65

  Montaner, Beatriz ^a   Pérez Tomás, Ricardo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BAFILOMYCIN A1; CALCINEURIN INHIBITOR; CYCLOPRODIGIOSIN; CYCLOSPORIN A; METACYCLOPRODIGIOSIN; METACYCLOPROGIDIOSIN; NONYLPRODIGIOSIN; NUCLEASE; PNU 156804; PRODIGIOSIN; PRODIGIOSIN DERIVATIVE; PROGIDIOSIN; PROGIDIOSINE; TACROLIMUS; UNCLASSIFIED DRUG; UNDECYLPRODIGIOSIN;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CARCINOGENESIS; CYTOTOXICITY; DNA CLEAVAGE; DRUG ACTIVITY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; NEPHROTOXICITY; NEUROTOXICITY;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL CYCLE; CELL SURVIVAL; HUMANS; PRODIGIOSIN; SIGNAL TRANSDUCTION;

EID: 0037303304     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009033333772     Document Type: Article

References (79)

1. Bennett, J. W.; Bentley, R. Seeing Red: The Story of Prodigiosin. Adv. Appl. Microbiol. 2000, 47, 1-32.
2. Starnes, C. O. Coley's Toxins in Perspective. Nature 1992, 357, 11-12.
3. Rook, G. Tumours and Coley's toxins. Nature 1992, 357, 545.
4. Wrede, F.; Rothhass, A. Uber das Prodigiosin, den Roten Farbstoff des Bacillus prodigiosus. Hoppe Seyler's Z. Chem. Ber. 1934, 226, 95.
5. Burger, S. R.; Bennett, J. W. Droplet Enrichment Factors of Pigmented and Nonpigmented Serratia marcescens: Possible Selective Function for Prodigiosin. Appl. Environ. Microbiol. 1985, 50, 487-490.
6. Matsuyama, T; Murakami, T.; Fujita, M.; Fujita, S.; Yano, I. Extracellular Vesicle Formation and Biosurfactant Production by Serratia marcescens. J. Gen. Microbiol. 1986, 132, 865-875.
7. Castro, A. J. Antimalarial Activity of Prodigiosin. Nature 1967, 213, 903-904.
8. Boger, D. L.; Patel, M. Total Synthesis Of Prodigiosin, Prodigiosene, and Desmethoxyprodigiosin: Diels-Alder Reactions of Heterocyclic Azadienes and Development of an Effective Palladium (II)-Promoted 2,2′-Bipyrrole Coupling Procedure. J. Org. Chem. 1988, 53, 1405-1415.
9. Kim, H. S.; Hayashi, M.; Shibata, Y.; Wataya, Y.; Mitamura, T.; Horii, T.; Kawauchi, K.; Hirata, H.; Tsuboi, S.; Moriyama, Y. Cycloprodigiosin Hydrochloride Obtained From Pseudoalteromonas denitrificans is a Potent Antimalarial Agent. Biol. Pharm. Bull. 1999, 22, 532-534.
10. Melo, P. S.; Durán, N.; Haun, M. Cytotoxicity of Prodigiosin and Benznidazole on V79 Cells. Toxicol. Lett. 2000, 116, 237-242.
11. D'alessio, R.; Rossi, A. Short Synthesis of Undecylprodigiosine. A New Route to 2,2′-Bipyrrolyl-Pyrromrthene Systems. Synlett 1996, 513-514.
12. Rizzo, V.; Morelli, A.; Pinciroli, V.; Sciangula, D.; D'alessio, R. Equilibrium and Kinetics of Rotamer Interconversion in Immunosuppressant Prodigiosin Derivatives in Solution. J. Pharm. Sci. 1999, 88, 73-78.
13. D'Alessio, R.; Bargiotti, A.; Carlini, O.; Colotta, F.; Ferrari, M.; Gnocchi, P.; Isetta, A.; Mongelli, N.; Motta, P.; Rossi, A.; Rossi, M.; Tibolla, M.; Vanotti, E. Synthesis and Immunosuppressive Activity of Novel Prodigiosin Derivatives. J. Med. Chem. 2000, 43, 2557-2565.
14. Melvin, M. S.; Tomlinson, J. T.; Saluta, G. R.; Kucera, G. L.; Lindquist, N.; Manderville, R. A. Double-Strand DNA Cleavage by Copper Prodigiosin. J. Am. Chem. Soc. 2000, 122, 6333-6334.
15. Nakamura, A.; Nagai, K.; Ando, K.; Tamura, G. Selective Suppression by Prodigiosin of the Mitogenic Response of Murine Splenocytes. J. Antibiot. 1986, 8, 1155-1159.
16. Nakamura, A.; Magae, J.; Tsuji, R. F.; Yamasaki, M.; Nagai, K. Suppression of Cytotoxic T Cell Induction In Vivo by Prodigiosin 25-C. Transplantation 1989, 47, 1013-1016.
17. Tsuji, R. F.; Yamamoto, M.; Nakamura, A.; Kataoka. T.; Magae, J.; Nagai, K.; Yamasaki, M. Selective Immunosuppression of Prodigiosin 25-C and FK506 in the Murine Immune System. J. Antibiot. 1990, 43, 1293-1301.
18. Tsuji, R. F.; Magae, J.; Jamashita, M.; Nagai, K.; Yamasaki, M. Immunomodulating Properties of Prodigiosin 25-C, An Antibiotic which Preferentially Suppresses of Cytotoxic T Cells. J. Antibiot. 1992, 45, 1295-1302.
19. +-ATPase. Biosci. Biotech. Biochem. 1995, 59, 1417-1421.
20. Magae, J.; Miller, M. W.; Nagai, K.; Shearer, G. M. Effect of Metacycloprodigiosin, an Inhibitor of Killer T Cells on Murine Skin and Heart Transplants. J. Antibios. 1996, 49, 86-90.
21. Songia, S.; Mortellaro, A.; Taverna, S.; Fornasiero, C.; Scheiber, E. A.; Erba, E.; Colotta, F.; Mantovani, A.; Isetta, A. M.; Golay, J. Characterization of the New Immunosuppresive Drug Undecylprodigiosin in Human Lymphocytes. J. Immunol. 1997, 158, 3987-3995.
22. Kawauchi, K.; Shibutani, K.; Yagisawa, H.; Kamata, H.; Nakatsuji, S.; Anzai, H., Yokoyama, Y.; Ikegami, Y.; Moriyama, Y.; Hirata, H. A Possible Immunosuppressant, Cycloprodigiosin Hydrochloride, Obtained from Pseudoalteromonas denitrificans. Biochem. Biophys. Res. Com. 1997, 237, 543-547.
23. Han, S. B.; Kim, H. M.; Kim, Y. H.; Lee, C. W.; Jang, E. S.; Son, K. H.; Kim, S. U.; Kim, Y. K. T-Cell Specific Immunosuppression by Prodigiosin Isolated from Serratia marcescens. Int. J. Immunopharmacol. 1998, 20, 1-13.
24. Lee, M. H.; Yamashita, M.; Tsuji, R. F.; Yamasaki, M.; Kataoka, T.; Magae, J.; Nagai, K. Suppression of T Cell Stimulating Function of Allogeneic Antigen Presenting Cells by Prodigiosin 25-C. J. Antibiot. 1998, 51, 92-94.
25. Mortellaro, A.; Songia, S.; Gnocchi, P.; Ferrari, M.; Fornasiero, C.; D'Alessio, R.; Isetta, A.; Colotta, F.; Golay, J. New Immunosuppressive Drug PNU156804 Blocks IL-2-Dependent Proliferation and NF-Kappa B and AP-1 Activation. J. Immunol. 1999, 162, 7102-7109.
26. + Mature Cytotoxic T Cells by Inhibitors of Acidification of Intracellular Organelles, Prodigiosin 25-C and Concanamycin B. Immunology 2000, 99, 243-248.
27. Azuma, T.; Watanabe, N.; Yagisawa, H.; Hirata, H.; Iwamura, M.; Kobayashi, Y. Induction of Apoptosis of Activated Murine Splenic T Cells by Cycloprodigiosin Hydrochloride, a Novel Immunosuppressant. Immunopharmacol. 2000, 46, 29-37.
28. Nakai, K.; Hamada, Y.; Kato, Y.; Yamamoto, D.; Hirata, H.; Hioki, K. Cycloprodigiosin Hydrocloride as an Immunosuppressant in Rat Small Bowel Transplantation. Transplant. Proc. 2000, 32, 1324-1325.
29. Fürstner, A.; Grabowski, J.; Lehmann, C. W.; Kataola, T.; Nagai, K. Synthesis and Biological Evaluation of Nonylprodigiosin and Macrocyclic Prodigiosin Analogues. Chem. BioChem. 2001, 2, 60-68.
30. Han, S. B.; Park, S. H.; Jeon, Y. J.; Kim, Y. K.; Kim, H. M.; Yang, K. H. Prodigiosin Blocks T Cell Activation by Inhibiting Interleukin-2Rα Expression and Delays Progression of Autoimmune Diabetes and Collagen-Induced Arthritis. J. Pharm. Exp. Ther. 2001, 299, 415-425.
31. Stepkowski, S. M.; Erwin-Cohen, R. A.; Behbod, F.; Wang, M. E.; Qu, X.; Tejpal, N.; Nagy, Z. S.; Kahan, B. D.; Kirken, R. A. Selective Inhibitor of Janus Tyrosine Kinase 3, PNU156804, Prolongs Allograft Survival and Acts Synergistically with Cyclosporine but Additively with Rapamycin. Blood 2002, 99, 680-689.
32. Moss, J. E.; Aliprantis, A. O.; Zychlinsky, A. The Regulation of Apoptosis by Microbial Pathogens. Int. Rev. Cytol. 1999, 187, 203-259.
33. Cameron, R.; Feuer, G. In Apoptosis and its Modulation By Drugs; Cameron, R.; Feuer, G., Eds. Springer-Verlag: Berlin, 2000, pp. 37-57.
34. Montaner, B.; Navarro, S.; Piqué, M.; Vilaseca, M.; Martinell, M.; Giralt, E.; Gil, J.; Pérez-Tomás, R. Prodigiosin from the Supernatant of Serratia marcescens Induces Apoptosis in Haematopoietic Cancer Cell Lines. Br. J. Pharmacol. 2000, 131, 585-593.
35. Montaner, B.; Pérez-Tomás, R. Prodigiosin-Induced Apoptosis in Human Colon Cancer Cells. Life Sci. 2001, 68, 2025-2036.
36. Díaz-Ruíz, C.; Montaner, B.; Pérez-Tomás, R. Prodigiosin Induces Cell Death and Morphological Changes Indicative of Apoptosis In Gastric Cancer Cell Line HGT-1. Histol. Histophatol. 2001, 16, 415-421.
37. - Symporter, Induces Apoptosis in Human Breast Cancer Cell Lines. J. Cancer Res. Clin. Oncol. 2000, 126, 191-197.
38. - Symporter, Induces Apoptosis and Differentiation in HL-60 Cells. Int. J. Cancer 2000, 88, 121-128.
39. - Symporter, Induces Apoptosis in Human Colon Cancer Cell Lines In Vitro. Oncol. Rep. 2001, 8, 821-824.
40. - Symporter, Induces Apoptosis in Human and Rat Hepatocellular Cancer Cell Lines In Vitro and Inhibits the Growth of Hepatocellular Carcinoma Xenografts in Nude Mice. Hepatology 1999, 30, 894-902.
41. 31P MRS as a Method of Measuring pH in Rat Tumours. NMR Biomed. 1992, 5, 351-359.
42. Shrode, L. D.; Tapper, H.; Grinstein, S. Role of Intracellular pH in Proliferation, Transformation, and Apoptosis. J. Bioenerg. Biomembr. 1997, 29, 393-399.
43. Martinez-Zaguilan, R.; Lynch, R. M.; Martinez, G. M.; Gillies, R. J. Vacuolar-Type H-ATPases are Functionally Expressed in Plasma Membranes of Human Tumor Cells. Am. J. Physiol. 1993, 265, 1015-1029.
44. Forgac, M. Structure and Function of Vacuolar Class of ATP-Driven Proton Pumps. Physiol. Rev. 1989, 69, 765-796.
45. Nelson, N. Evolution of Organellar Proton-ATPases. Biochim. Biophys. Acta 1992, 1100, 109-124.
46. Arends, M. J.; Wyllie, A. H. Apoptosis: Mechanisms and Roles in Pathology. Int. Rev. Esp. Pathol. 1991, 32, 223-256.
47. Thangaraju, M.; Sharma, K.; Liu, D.; Shen, S. H.; Srikant, C. B. Interdependent Regulation of Intracellular Acidification and SHP-1 in Apoptosis. Cancer Res. 1999, 59, 1649-1654.
48. Matsuyama, S.; Llopis, J.; Deveraux, Q. L.; Tsien, R. Y.; Reed, J. C. Changes in Intramitochondrial and Cytosolic pH: Early Events that Modulate Caspase Activation During Apoptosis. Nat. Cell Biol. 2000, 2, 318-325.
49. +-ATPases Induce Apoptotic Cell Death. Biochem. Biophys. Res. Commun. 1995, 212, 255-262.
50. Yamagata, M.; Tannock, I. F. The Chronic Administration of Drugs that Inhibit the Regulation of Intracellular pH: In Vitro and Anti-Tumour Effects. Br. J. Cancer 1996, 73, 1328-1334.
51. - Symporters that Uncouple Proton Translocators. J. Biol. Chem. 1998, 273, 21455-21462.
52. - Requirement for Inhibition of Vacuolar Acidification by Cycloprodigiosin In Situ. Plant. Cell. Physiol. 2000, 41, 857-863.
53. - Symport Activity. J. Biochem. 1998, 124, 547-556.
54. +-Atpase, Inhibits Vacuolar Acidification and Effects Glycoprotein Processing. FEBS Lett. 1995, 359, 53-59.
55. +)-ATPpase by Prodigiosins. Biochem. Pharmacol. 2000, 60, 1655-1663.
56. Vander Heiden, M. G.; Thompson, C. B. Bcl-2 Proteins: Regulators of Apoptosis or of Mitochondrial Homeostasis? Nat. Cell. Biol. 1999, 1, 209-216.
57. Hussain, S. P.; Harris, C. C. Molecular Epidemiology of Human Cancer: Contribution of Mutation Spectra Studies for Tumor Suppressor Genes. Cancer Res. 1998, 58, 4023-4037.
58. Kirsch, D. G.; Kastan, M. B. Tumor Suppressor p53: Implications for Tumor Development and Prognosis. J. Clin. Oncol. 1998, 16, 3158-3168.
59. Wang, M. E.; Kirken, R.; Behbod, F.; Erwin-Cohen, R.; Stepkowski, S. M.; Kahan, B. D. Inhibition of Jak3 Tyrosine Kinase by PNU156804 Blocks Rat Heart Allograft Rejection. Transplant. Proc. 2001, 33, 201.
60. Brown, J. M.; Wouters, B. G. Apoptosis, p53, and Tumor Cell Sensitivity to Anticancer Agents. Cancer Res. 1999, 59, 1391-1399.
61. Bunz, F.; Hwang, P. M.; Torrance, C.; Waldman, T.; Zhang, Y.; Dillehay, L.; Williams, J.; Lengauer, C.; Kinzler, K. W.; Vogelstein, B. Disruption of p53 in Human Cancer Cells Alters the Responses to Therapeutic Agents. J. Clin. Invest. 1999, 104, 263-269.
62. Xia, Z.; Dickens, M.; Raingeaud, J.; Davis, R. J.; Greenberg, M. E. Opposing Effects of ERK and JNK-P38 MAP Kinases on Apoptosis. Science 1995, 270, 1326-1331.
63. Mansat, V.; Laurent, G.; Levade, T.; Bettaieb, A.; Jaffrezou, J. P. The Protein Kinase C Activators Phorbol Esters and Phosphatidylserine Inhibit Neutral Sphingomyelinase Activation, Ceramide Generation, and Apoptosis Triggered by Daunorubicin. Cancer Res. 1997, 57, 5300-5304.
64. ++ Dependent Endonuclease With Protein Kinase C as a Possible Mechanism for Cytokine Resistance in Human Renal Carcinoma Cells. J. Urol. 1996, 155, 1779-1783.
65. Tomei, L. D.; Kanter, P.; Wenner, C. E. Inhibition of Radiation-Induced Apoptosis In Vitro by Tumor Promoters. Biochem. Biophys. Res. Commun. 1988, 155, 324-331.
66. Zanke, B. W.; Lee, C.; Arab, S.; Tannock, I. F. Death of Tumor Cells after Intracellular Acidification is Dependent on Stress-Activated Protein Kinases (SAPK/JNK) Pathway Activation and Cannot Be Inhibited by Bcl-2 Expression or Interleukin 1B-Converting Enzyme Inhibition. Cancer Res. 1998, 58, 2801-2808.
67. Montaner, B.; Pérez-Tomás, R. Activation of Protein Kinase C is Required for Protection of Cells Against Apoptosis Induced by the Immunossuppresor Prodigiosin. Biochem. Pharmacol. 2002, 63, 463-469.
68. Faris, M.; Kokot, N.; Latinis, K.; Kasibhatla, S.; Green, D. R.; Koretzky, G. A.; Nel, A. The c-Jun N-Terminal Kinase Cascade Plays a Role In Stress-Induced Apoptosis in Jurkat Cells by Up-Regulating Fas Ligand Expression. J. Immunol. 1998, 160, 134-144.
69. Frasch, S. C.; Nick, J. A.; Fadok, V. A.; Bratton, D. L.; Worthen, G. S.; Henson, P. M. p38 Mitogen-Activated Protein Kinase-Dependent and -Independent Intracellular Signal Transduction Pathways Leading to Apoptosis in Human Neutrophils. J. Biol. Chem. 1998, 273, 8389-8397.
70. Montaner, B.; Pérez-Tomás, R. The Cytotoxic Prodigiosin Induces Phosphorylation of p38-MAPK but not of SAPK/JNK. Toxicol. Lett. 2002, 129, 93-98.
71. Fürstner, A.; Grabowski, E. J. Studies on DNA Cleavage by Cytotoxic Pyrrole Alkaloids Reveal the Distinctly Different Behavior of Roseophilin and Prodigiosin Derivatives. Chem. BioChem. 2001, 9, 706-709.
72. Melvin, M. S.; Ferguson, D. C.; Lindquist, N.; Manderville, R. A. DNA Binding by 4-Methoxypurrolic Natural Products. Preference for Intercalation at AT Sites by Tambjamine E and Prodigiosin. J. Org. Chem. 1999, 64, 6861-6869.
73. Khanna, K. K; Jackson, S. P. DNA Double-Strand Breaks: Signaling, Repair and the Cancer Connection. Nat. Genet. 2001, 27, 247-254.
74. Wike-Hooley, J. L.; Haveman, J.; Reinhold, J. S. The Relevance of Tumor pH to the Treatment of Malignant Disease. Radiother. Oncol. 1984, 2, 343-366.
75. Kozin, S.; Shkarin, P.; Gerweck, L. The cell Transmembrane pH Gradient in Tumors Enhances Cytotoxicity of Specific Weak Acid Chemotherapeutics. Cancer Res. 2001, 61, 4740-4743.
76. Fullan, N. P.; Lynch, D. L; Ostrow, D. H. Effects of Bacterial Extracts on Chinese Hamster Cells and Rat Neoplasms. Microbios Lett. 1977, 5, 157-161.
77. Lai, K. S.; Jin, Y.; Graham, D. K.; Witthuhn, B. A.; Ihle, J. N.; Liu, E. T. A Kinase-Deficient Splice Variant of the Human Jak3 is Expressed in Hematopoietic and Epithelial Cancer Cells. J. Biol. Chem. 1995, 270, 25028-25036.
78. Hannun, Y. A. Apoptosis and the Dilemma of Cancer Chemotherapy. Blood 1997, 89, 1845-1853.
79. Monks, A.; Scudiero, D. A.; Johnson, G. S.; Paull, K. D.; Sausville, E. A. The NCI Anti-Cancer Drug Screen: A Smart Screen to Identify Effectors of Novel Targets. Anticancer Drug Des. 1997, 12, 533-541.